Pathogenic mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most frequent known cause of monogenic PD and are usually associated with a toxic gain-of-function of LRRK2 kinase activity (Zimprich et al., 2004; Healy et al., 2008). The gene discussed is LRRK2; the disease is Parkinson disease.